AI Verdict
RFL has stronger fundamentals based on our AI analysis.
RGBPP vs RFL Fundamental Comparison
| Metric | RGBPP | RFL |
|---|---|---|
| Revenue | $59,065.0 | $451,000.0 |
| Net Income | $-967,853.0 | $-16.2M |
| Net Margin | -1,638.6% | -3,599.3% |
| ROE | N/A | -20.5% |
| ROA | -408.2% | -16.3% |
| Current Ratio | 0.03x | 3.44x |
| Debt/Equity | N/A | 0.00x |
| EPS | $-0.01 | $-0.32 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
RGBPP vs RFL: Frequently Asked Questions
Is RGBPP or RFL a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), RFL has stronger fundamentals. RGBPP is rated STRONG SELL (95% confidence) while RFL is rated SELL (72% confidence). This is not investment advice.
How does RGBPP compare to RFL fundamentally?
Regen BioPharma Inc has ROE of N/A vs Rafael Holdings, Inc.'s -20.5%. Net margins are -1,638.6% vs -3,599.3% respectively.
Which stock pays higher dividends, RGBPP or RFL?
RGBPP has a dividend yield of N/A or no dividend while RFL has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in RGBPP or RFL for long term?
For long-term investing, consider that RGBPP has STRONG SELL rating with 95% confidence, while RFL has SELL rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about RGBPP vs RFL?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For RGBPP vs RFL, the AI consensus favors RFL based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.